Rapid Relief Cold Relief Patch

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor pain.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and older, the following dosage and administration guidelines apply:

The patch should be applied to the affected area after carefully removing the backing. The sticky side of the patch must be placed directly onto the skin. Each patch may be worn for a maximum of 8 hours. If necessary, the application may be repeated, but no more than three patches should be used in a 24-hour period. After a single use, the patch must be discarded appropriately. It is important to reseal the pouch after opening to maintain the integrity of the remaining patches.

For children under 12 years of age, it is recommended to consult a physician prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

Application on wounds, cuts, damaged, or infected skin is prohibited due to the potential for exacerbating the condition and delaying healing. Additionally, the product should not be applied to the eyes, mouth, genitals, or any mucous membranes, as this may lead to irritation or adverse reactions.

When utilizing this product, it is essential to avoid tight bandaging or the use of heating pads, as these practices may increase the risk of skin irritation or other complications. Furthermore, concurrent use with other topical analgesics is contraindicated to prevent potential interactions and enhance safety.

Warnings and Precautions

For external use only. This product is contraindicated for application on wounds, cuts, damaged or infected skin. It should not be applied to the eyes, mouth, genitals, or any other mucous membranes.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following occur: the condition worsens; redness is observed; irritation develops; symptoms persist for more than 7 days or resolve and then recur within a few days; or if signs of skin injury, such as pain, swelling, or blistering, are experienced at the site of application. Additionally, pregnant or breastfeeding individuals should consult a healthcare professional prior to use.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (800-222-1222) should be contacted without delay.

Side Effects

Patients should be aware that the product is intended for external use only.

In clinical practice, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, presence of redness, development of irritation, persistence of symptoms beyond 7 days, or if symptoms resolve and then recur within a few days. Additionally, patients should seek medical advice if they experience signs of skin injury, which may include pain, swelling, or blistering at the site of application.

For pregnant or breastfeeding individuals, it is recommended to consult a healthcare professional prior to use to ensure safety and appropriateness of the product.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Rapid Relief Cold Relief Patch (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use the patch as directed. The patch should be applied by carefully removing the backing and placing the sticky side on the affected area. It is recommended to wear one patch for up to 8 hours, with the possibility of repeating this process as necessary, not exceeding three applications in a 24-hour period. Each patch is for single use only and should be discarded after use. The pouch should be resealed after opening to maintain the integrity of the remaining patches.

For children under 12 years of age, consultation with a physician is advised prior to use. It is important to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact a Poison Control Center at 800-222-1222.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and breastfeeding safety. Healthcare providers can offer guidance tailored to individual circumstances, ensuring informed decision-making for both maternal and fetal health.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the available data. Therefore, healthcare professionals should exercise caution when prescribing to this population, as the lack of information necessitates careful clinical judgment regarding the use of the medication in individuals with reduced kidney function. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, and specific interventions may be required based on the symptoms presented.

Management of an overdose may involve the administration of activated charcoal if the patient presents within a suitable timeframe and is not at risk for aspiration. In cases of severe toxicity, advanced interventions such as airway management, intravenous fluids, or antidotes may be indicated, depending on the specific agent involved.

It is crucial for healthcare professionals to consult local poison control centers or toxicology experts for guidance on the management of overdose cases, as they can provide tailored recommendations based on the latest evidence and clinical protocols.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 800-222-1222 if the product is swallowed. It is important to instruct patients not to use the product on wounds, cuts, damaged, or infected skin, and to avoid application on the eyes, mouth, genitals, or any other mucous membranes.

Patients should be informed to discontinue use and consult a doctor if any of the following occur: the condition worsens, redness is present, irritation develops, symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. Additionally, patients should seek medical attention if they experience signs of skin injury, such as pain, swelling, or blistering at the site of application.

For those who are pregnant or breastfeeding, it is essential to recommend consulting a healthcare professional before using the product. When using this product, patients should be instructed to follow the directions carefully. They should be made aware that rare cases of serious burns have been reported with similar products. It is crucial to advise against tightly bandaging the area or using a heating pad in conjunction with the product. Patients should also be reminded to avoid contact with eyes and mucous membranes, refrain from applying the product to wounds or damaged skin, and not to use it simultaneously with other topical analgesics.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 15-30℃ (59-86℉) to maintain its efficacy. Additionally, the product should be kept out of reach of children to ensure safety. Proper handling and storage conditions are crucial for preserving the integrity of the product.

Additional Clinical Information

The product is administered topically, with a recommended usage of one patch for up to 8 hours. Patients may repeat this application as necessary, but should not exceed three applications in a single day.

Clinicians should counsel patients to consult a healthcare professional if they are pregnant or breastfeeding prior to use. It is also crucial to advise patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center at 800-222-1222 if the product is swallowed.

Drug Information (PDF)

This file contains official product information for Rapid Relief Cold Relief Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)